
Anish Gupta
Examiner (ID: 17158)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1811, 6221, PCTL, IPLA, 1653 |
| Total Applications | 1025 |
| Issued Applications | 530 |
| Pending Applications | 179 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6739765
[patent_doc_number] => 20030157134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method for treating a non-rhinorrhea cholinergic influenced secretion'
[patent_app_type] => new
[patent_app_number] => 10/365082
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5028
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365082
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365082 | Method for treating a non-rhinorrhea cholinergic influenced secretion | Feb 10, 2003 | Abandoned |
Array
(
[id] => 6702098
[patent_doc_number] => 20030224978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Compounds and methods for modulating apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/359546
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23284
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224978.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359546 | Compounds and methods for modulating apoptosis | Feb 3, 2003 | Issued |
Array
(
[id] => 498694
[patent_doc_number] => 07204994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Juvenile hormone compositions and methods for making same'
[patent_app_type] => utility
[patent_app_number] => 10/356731
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 8796
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/204/07204994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356731 | Juvenile hormone compositions and methods for making same | Feb 2, 2003 | Issued |
Array
(
[id] => 478711
[patent_doc_number] => 07223726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same'
[patent_app_type] => utility
[patent_app_number] => 10/342965
[patent_app_country] => US
[patent_app_date] => 2003-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 11856
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223726.pdf
[firstpage_image] =>[orig_patent_app_number] => 10342965
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/342965 | Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same | Jan 13, 2003 | Issued |
Array
(
[id] => 758037
[patent_doc_number] => 07015195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Treatment of bone disorders with skeletal anabolic drugs'
[patent_app_type] => utility
[patent_app_number] => 10/340484
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 33094
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10340484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/340484 | Treatment of bone disorders with skeletal anabolic drugs | Jan 9, 2003 | Issued |
Array
(
[id] => 6856692
[patent_doc_number] => 20030130193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'GCSF conjugates'
[patent_app_type] => new
[patent_app_number] => 10/331434
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7211
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331434 | GCSF conjugates | Dec 29, 2002 | Abandoned |
Array
(
[id] => 6642088
[patent_doc_number] => 20030212248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Process to increase protein stability'
[patent_app_type] => new
[patent_app_number] => 10/311782
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7697
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311782 | Process to increase protein stability | Dec 17, 2002 | Abandoned |
Array
(
[id] => 6822073
[patent_doc_number] => 20030220234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Deuterated cyclosporine analogs and their use as immunodulating agents'
[patent_app_type] => new
[patent_app_number] => 10/319835
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10314
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319835 | Deuterated cyclosporine analogs and their use as immunodulating agents | Dec 15, 2002 | Abandoned |
Array
(
[id] => 7122850
[patent_doc_number] => 20050014679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Insulin molecule having protracted time action'
[patent_app_type] => utility
[patent_app_number] => 10/496847
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28162
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496847 | Insulin molecule having protracted time action | Dec 11, 2002 | Abandoned |
Array
(
[id] => 7280371
[patent_doc_number] => 20040062748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/317092
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23510
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20040062748.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317092 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | Dec 11, 2002 | Abandoned |
Array
(
[id] => 6627954
[patent_doc_number] => 20030211065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods and compositions for diagnosing and treating hypotrichosis simplex'
[patent_app_type] => new
[patent_app_number] => 10/316175
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9188
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10316175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/316175 | Methods and compositions for diagnosing and treating hypotrichosis simplex | Dec 8, 2002 | Abandoned |
Array
(
[id] => 6851530
[patent_doc_number] => 20030143733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Tetrapeptide'
[patent_app_type] => new
[patent_app_number] => 10/313928
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3393
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313928 | Tetrapeptide | Dec 5, 2002 | Abandoned |
Array
(
[id] => 6791541
[patent_doc_number] => 20030086885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Hair-growing agent'
[patent_app_type] => new
[patent_app_number] => 10/309047
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4136
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309047 | Hair-growing agent | Dec 3, 2002 | Issued |
Array
(
[id] => 6870575
[patent_doc_number] => 20030083265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'TGF-beta inhibitors and methods'
[patent_app_type] => new
[patent_app_number] => 10/304586
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4264
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304586 | TGF-beta inhibitors and methods | Nov 24, 2002 | Abandoned |
Array
(
[id] => 6851460
[patent_doc_number] => 20030143663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Process for preparing insulin compounds'
[patent_app_type] => new
[patent_app_number] => 10/299183
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8161
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299183 | Process for preparing insulin compounds | Nov 18, 2002 | Issued |
Array
(
[id] => 352668
[patent_doc_number] => 07491690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Self-assembly and mineralization of peptide-amphiphile nanofibers'
[patent_app_type] => utility
[patent_app_number] => 10/294114
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 7146
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294114 | Self-assembly and mineralization of peptide-amphiphile nanofibers | Nov 13, 2002 | Issued |
Array
(
[id] => 7351190
[patent_doc_number] => 20040248792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Thymosin alpha 1 peptide/.polymer conjugates'
[patent_app_type] => new
[patent_app_number] => 10/493690
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2696
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248792.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493690 | Thymosin alpha 1 peptide/polymer conjugates | Oct 31, 2002 | Issued |
Array
(
[id] => 6697264
[patent_doc_number] => 20030109458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'DI-, TRI-, and tetra-peptides having antiangiogenic activity'
[patent_app_type] => new
[patent_app_number] => 10/284227
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12793
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10284227
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/284227 | Di-, tri-, and tetra-peptides having antiangiogenic activity | Oct 29, 2002 | Issued |
Array
(
[id] => 6801222
[patent_doc_number] => 20030096387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/282588
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7718
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10282588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/282588 | Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor | Oct 27, 2002 | Abandoned |
Array
(
[id] => 6855687
[patent_doc_number] => 20030129188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Integrin targeting compounds'
[patent_app_type] => new
[patent_app_number] => 10/278539
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13941
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278539 | Integrin targeting compounds | Oct 21, 2002 | Abandoned |